Does USTEKINUMAB Cause Visual impairment? 737 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 737 reports of Visual impairment have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.9% of all adverse event reports for USTEKINUMAB.
737
Reports of Visual impairment with USTEKINUMAB
0.9%
of all USTEKINUMAB reports
373
Deaths
301
Hospitalizations
How Dangerous Is Visual impairment From USTEKINUMAB?
Of the 737 reports, 373 (50.6%) resulted in death, 301 (40.8%) required hospitalization, and 259 (35.1%) were considered life-threatening.
Is Visual impairment Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 737 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Visual impairment?
INSULIN GLARGINE (5,793)
INSULIN LISPRO (4,654)
ADALIMUMAB (3,770)
DUPILUMAB (3,089)
ETANERCEPT (2,489)
FINGOLIMOD (2,147)
AFLIBERCEPT (1,836)
PREGABALIN (1,714)
METHOTREXATE (1,588)
TOFACITINIB (1,544)
Which USTEKINUMAB Alternatives Have Lower Visual impairment Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE